Avet-Loiseau H - Search Results

1

Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy.

Moreau P, Facon T, Leleu X, Morineau N, Huyghe P, Harousseau JL, Bataille R, Avet-Loiseau H; Intergroupe Francophone du Myélome. Moreau P, et al. Blood. 2002 Sep 1;100(5):1579-83. doi: 10.1182/blood-2002-03-0749. Blood. 2002. PMID: 12176874 Free article.

2

CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.

Chevallier P, Penther D, Avet-Loiseau H, Robillard N, Ifrah N, Mahé B, Hamidou M, Maisonneuve H, Moreau P, Jardel H, Harousseau JL, Bataille R, Garand R. Chevallier P, et al. Br J Haematol. 2002 Jan;116(1):142-50. doi: 10.1046/j.0007-1048.2001.3205.x. Br J Haematol. 2002. PMID: 11841407 Free article.

3

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation.

Avet-Loiseau H, Facon T, Grosbois B, Magrangeas F, Rapp MJ, Harousseau JL, Minvielle S, Bataille R; Intergroupe Francophone du Myélome. Avet-Loiseau H, et al. Blood. 2002 Mar 15;99(6):2185-91. doi: 10.1182/blood.v99.6.2185. Blood. 2002. PMID: 11877296 Free article.

4

Current treatment strategies for multiple myeloma.

Grosbois B, Decaux O, Azais I, Facon T, Avet-Loiseau H. Grosbois B, et al. Eur J Intern Med. 2002 Mar;13(2):85-95. doi: 10.1016/s0953-6205(01)00205-9. Eur J Intern Med. 2002. PMID: 11893464

5

Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.

Spisek R, Chevallier P, Morineau N, Milpied N, Avet-Loiseau H, Harousseau JL, Meflah K, Gregoire M. Spisek R, et al. Cancer Res. 2002 May 15;62(10):2861-8. Cancer Res. 2002. PMID: 12019165

6

Activating Ras mutations in patients with plasma-cell disorders: a reappraisal.

Bezieau S, Avet-Loiseau H, Moisan JP, Bataille R. Bezieau S, et al. Blood. 2002 Aug 1;100(3):1101-2; author reply 1103. doi: 10.1182/blood-2002-03-0795. Blood. 2002. PMID: 12150155 Free article. No abstract available.

7

Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants.

Avet-Loiseau H, Garand R, Lodé L, Harousseau JL, Bataille R; Intergroupe Francophone du Myélome. Avet-Loiseau H, et al. Blood. 2003 Feb 15;101(4):1570-1. doi: 10.1182/blood-2002-08-2436. Epub 2002 Oct 3. Blood. 2003. PMID: 12393502 Free article.

8

Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease.

Magrangeas F, Nasser V, Avet-Loiseau H, Loriod B, Decaux O, Granjeaud S, Bertucci F, Birnbaum D, Nguyen C, Harousseau JL, Bataille R, Houlgatte R, Minvielle S. Magrangeas F, et al. Blood. 2003 Jun 15;101(12):4998-5006. doi: 10.1182/blood-2002-11-3385. Epub 2003 Mar 6. Blood. 2003. PMID: 12623842 Free article.

9

CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma.

Robillard N, Avet-Loiseau H, Garand R, Moreau P, Pineau D, Rapp MJ, Harousseau JL, Bataille R. Robillard N, et al. Blood. 2003 Aug 1;102(3):1070-1. doi: 10.1182/blood-2002-11-3333. Epub 2003 Apr 17. Blood. 2003. PMID: 12702507 Free article.

10

14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.

Avet-Loiseau H, Garand R, Lodé L, Robillard N, Bataille R. Avet-Loiseau H, et al. Semin Oncol. 2003 Apr;30(2):153-5. doi: 10.1053/sonc.2003.50053. Semin Oncol. 2003. PMID: 12720126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters